JACOBS LEVY EQUITY MANAGEMENT, INC
Position in NKTR — Nektar Therapeutics
CIK 884414
FLORHAM PARK, NJ
Position in NKTR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,007,707
-$1,160,937 QoQ
Shares Held
14,435
-52.1% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#121
of 239 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NKTR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026JACOBS LEVY EQUITY MANAGEMENT, INC holds $741,570,791 across 81 Biotechnology names. NKTR ranks #55 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
256,503 | $159,939,880 | |
| 2 | RARE |
Ultragenyx Pharmaceutical Inc.
|
2,939,719 | $98,157,217 | |
| 3 | INCY |
Incyte Corp
|
731,774 | $82,953,900 | |
| 4 | CORT |
Corcept Therapeutics Inc
|
695,532 | $60,476,507 | |
| 5 | HALO |
Halozyme Therapeutics, Inc.
|
322,377 | $25,232,447 | |
| 6 | EXEL |
Exelixis, Inc.
|
415,650 | $22,615,516 | |
| 7 | AUPH |
Aurinia Pharmaceuticals Inc.
|
1,231,516 | $20,898,826 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
60,986 | $18,358,615 |
All Filings in NKTR
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,007,707 | 14,435 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $2,168,644 | 30,141 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $615,765 | 14,564 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $850,427 | 14,946 | Shares | Sole | 2025-11-17 | |
| 2025-06-30 | $3,830,521 | 148,240 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,045,391 | 3,007,928 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $2,443,073 | 2,626,961 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $3,631,165 | 2,793,204 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,562,758 | 2,873,192 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $1,777,402 | 1,911,186 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,906,332 | 3,404,165 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $2,942,847 | 4,904,745 | Shares | Sole | 2023-11-17 | |
| 2023-06-30 | $2,824,877 | 4,870,478 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $1,832,660 | 2,618,087 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $5,810,118 | 2,570,849 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,321,372 | 1,037,929 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $866,259 | 227,963 | Shares | Sole | 2022-08-15 | |
| 2021-12-31 | $1,255,308 | 92,917 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,563,992 | 87,082 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $437,253 | 25,481 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $392,140 | 19,607 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $1,283,092 | 75,476 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $1,273,796 | 76,781 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,355,439 | 58,525 | Shares | Sole | 2020-08-17 | |
| No filing history on record for this holder in this stock. | ||||||